Advanced Lung Cancer
49
15
15
13
Key Insights
Highlights
Success Rate
81% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
6.1%
3 terminated out of 49 trials
81.3%
-5.3% vs benchmark
0%
0 trials in Phase 3/4
8%
1 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (49)
A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Evidence-Based Nursing Plus Progressive Exercise for Cancer-Related Fatigue in Advanced Lung Cancer
Family-Supported Palliative Care in Advanced Lung Cancer
Targeting PD-L1 and TIGIT in Tumors With Tertiary Lymphoid Structures
A Digital Health Intervention to Improve Physical Function and Wellness of Lung Cancer Survivors
Engage Psychosocial Intervention for Cancer Symptoms
Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients
Tier Palliative Care For Patients With Advanced Heart Failure or Cancer
Inhaled mRNA Tumor-associated Antigen Dry Powder Vaccine in Advanced Lung Cancer and Lung Metastasis of Solid Tumors.
A Phase II Clinical Study Evaluating the Combination Therapy of JS212 in Patients With Advanced Lung Cancer
The Efficacy and Safety of ARNI on the Outcome of Advanced Lung Cancer With Concurrent Hypertension
JS004 Combined With Toripalimab and With Standard Chemotherapy Treat Patients With Advanced Lung Cancer
A Study of MHB036C Combined With Anti-tumor Therapies in Patients With Advanced Lung Cancer
Multi-site Trial of a Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer
Tier - Palliative Care For Patients With Advanced Heart Failure or Cancer
Clinical Study of AL2846 Capsules in the Treatment of Advanced Lung Tumor and Advanced Ovarian Cancer
A Clinical Study of BT02 in Treating Patients With Advanced Lung Cancer
Clinical Study on Chimeric Antigen Receptor T Lymphocyte (CAR-T) Targeting CEA for the Treatment of CEA - Positive Advanced Lung Cancer